In vitro antimycobacterial activities of pyrazinamide analogs : Results of screening tests

Kekkaku

Volumn 71, Issue 3, 1996, Pages 253-258

  Yamamoto, Setsuko ^a   Toida, Ichiro ^b   Watanabe, Nanao ^b   Ura, Toshikazu ^b  

^a RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

N (HYDROXYMETHYL)PYRAZINECARBOTHIOAMIDE; PYRAZINAMIDE; PYRAZINECARBOTHIOAMIDE; PYRAZINOIC ACID OCTYL ESTER; PYRAZINOIC ACID PIVALOYLOXYMETHYL ESTER; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG SCREENING; DRUG SENSITIVITY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DRUG EVALUATION, PRECLINICAL; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM; PYRAZINAMIDE;

EID: 0029919878     PISSN: 00229776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Mackaness GB : The intracellular activation of pyrazinamide and nicotinamide. Am Rev Tuberc Pulm Dis. 1956 ; 74 : 718-728.
2. Mc Dermott W, Tompsett R : Activation of pyrazinamide and nicotinamide in acidic environments in vitro. Am Rev Tuberc. 1954 ; 70 : 748-754.
3. Steele MA, Des Prez RM : The role of pyrazinamide in tuberculosis chemotherapy. Chest. 1988 ; 94 : 845-850.
4. Snider DE Jr, Raviglione M, Kochi A : Global burden of tuberculosis. In : Tuberculosis : Pathogenesis, protection, and control, Bloom BR, ed. American Society for Microbiology, Washington, D.C., 1994 ; 3-11.
5. Chin DP : Mycobacterium avium complex and other nontuberculous mycobacterial infections in patients with HIV. Seminars in Respir Infect. 1993 ; 8 : 124-138.
6. Horsburgh CR Jr : Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. New Engl J Med. 1991 ; 324 : 1332-1338.
7. Hall SA, Spoerri PE : Syntheses in the pyrazine series. II. Preparation and properties of aminopyrazine. J Am Chem Soc. 1940 ; 62 : 664-665.
8. Dessau FI, Yeager RL, Burger FJ, et al. : Pyrazinamide (Aldinamide) in experimental tuberculosis of the guinea pig. Am Rev Tuber. 1952 ; 65 : 519-522.
9. Dessau FI, Burger FJ, Yeager RL, et al. : A method for the determination of in vitro sensitivity of tubercle bacilli to pyrazinamide (Aldinamide). Am Rev Tuberc. 1952 ; 65 : 635-636.
10. Malone L, Schurr A, Lindh H, et al. : The effect of pyrazinamide (Aldinamide) on experimental tuberculosis in mice. Am Rev Tuberc. 1952 ; 65 : 511-518.
11. Yeager RL, Munroe WGC, Dessau FI : Pyrazinamide (Aldinamide) in the treatment of pulmonary tuberculosis. Am Rev Tuberc. 1952 ; 65 : 523-545.
12. Kushner S, Dalalian H, Sanjurjo JL, et al. : Experimental chemotherapy of tuberculosis. II. The synthesis of pyrazinamides and related compounds. J Am Chem Soc. 1952 ; 74 : 3617-3621.
13. McCune RM Jr, Tompsett R, McDermott W : The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial ennumeration techniques. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug. J Exp Med. 1956 ; 104 : 763-802.
14. American Thoracic Society : Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med. 1994 ; 149 : 1359-1374.
15. Fox W : Short-course chemotherapy for pulmonary tuberculosis and some problems of its programme application with particular reference to India. Bull Internatl Union - Against Tuberc. 1985 ; 60 : 40-49.
16. Konno K, Feldmann FM, McDermott W : Pyrazinamide susceptibility and amidase activity of tubercle bacilli. Am Rev Respir Dis. 1967 ; 95 : 461-469.
17. Heifets LB, Flory MA, Lindholm-Levy PJ : Does pyrazinoic acid as an active moiety of pyrazinamide have specific activity against Mycobacterium tuberculosis? Antimicrob Agents Chemother. 1989 ; 33 : 1252-1254.
18. Salfinger M, Crowle AJ, Relier LB : Pyrazinamide and pyrazinoic acid activity against tubercle bacilli in cultured human macrophages and in the BACTEC system. J Infect Dis, 1990 ; 162 : 201-207.
19. Yamamoto S, Toida I, Watanabe N, et al. : In vitro antimycobacterial activities of pyrazinamide analogs. Antimicrob Agents Chemother. 1995 ; 39 : 2088-2091.
20. Salfinger M, Heifets LB : Determination of pyrazinamide MICs for Mycobacterium tuberculosis at different pHs by the radiometric method. Antimicrob Agents Chemother. 1988 ; 32 : 1002-1004.
21. Heifets LB : Drug susceptibility tests in the management of chemotherapy of tuberculosis. In : Drug susceptibility in the chemotherapy of mycobacterial infections, Heifets LB, ed. CRC Press, Boca Raton, Ann Arbor, Boston, London, 1991;89-121.